nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR7—vas deferens—prostate cancer	0.0583	0.669	CbGeAlD
Amisulpride—HTR2A—urine—prostate cancer	0.00904	0.104	CbGeAlD
Amisulpride—HTR7—epithelium—prostate cancer	0.00383	0.0439	CbGeAlD
Amisulpride—HTR7—renal system—prostate cancer	0.00355	0.0407	CbGeAlD
Amisulpride—Metoclopramide—CYP17A1—prostate cancer	0.00305	1	CrCbGaD
Amisulpride—HTR2A—epithelium—prostate cancer	0.00239	0.0274	CbGeAlD
Amisulpride—HTR7—testis—prostate cancer	0.00229	0.0263	CbGeAlD
Amisulpride—HTR2A—renal system—prostate cancer	0.00221	0.0254	CbGeAlD
Amisulpride—DRD2—testis—prostate cancer	0.00217	0.0249	CbGeAlD
Amisulpride—HTR2B—lymph node—prostate cancer	0.00194	0.0223	CbGeAlD
Amisulpride—HTR2A—testis—prostate cancer	0.00143	0.0164	CbGeAlD
Amisulpride—Pruritus—Goserelin—prostate cancer	0.000512	0.000689	CcSEcCtD
Amisulpride—Somnolence—Estradiol—prostate cancer	0.00051	0.000686	CcSEcCtD
Amisulpride—Weight increased—Prednisone—prostate cancer	0.00051	0.000686	CcSEcCtD
Amisulpride—Pruritus—Conjugated Estrogens—prostate cancer	0.000508	0.000683	CcSEcCtD
Amisulpride—Weight decreased—Prednisone—prostate cancer	0.000507	0.000682	CcSEcCtD
Amisulpride—Hyperglycaemia—Prednisone—prostate cancer	0.000506	0.00068	CcSEcCtD
Amisulpride—Dyspepsia—Estradiol—prostate cancer	0.000505	0.00068	CcSEcCtD
Amisulpride—Hypotension—Mitoxantrone—prostate cancer	0.0005	0.000672	CcSEcCtD
Amisulpride—Depression—Prednisone—prostate cancer	0.000499	0.000671	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Estradiol—prostate cancer	0.000496	0.000667	CcSEcCtD
Amisulpride—Diarrhoea—Goserelin—prostate cancer	0.000496	0.000666	CcSEcCtD
Amisulpride—Fatigue—Estradiol—prostate cancer	0.000495	0.000666	CcSEcCtD
Amisulpride—Constipation—Estradiol—prostate cancer	0.000491	0.00066	CcSEcCtD
Amisulpride—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000491	0.00066	CcSEcCtD
Amisulpride—Neuropathy peripheral—Prednisone—prostate cancer	0.00049	0.000659	CcSEcCtD
Amisulpride—Leukopenia—Etoposide—prostate cancer	0.000488	0.000656	CcSEcCtD
Amisulpride—Cardiac disorder—Docetaxel—prostate cancer	0.000483	0.00065	CcSEcCtD
Amisulpride—Cardiac arrest—Epirubicin—prostate cancer	0.000483	0.000649	CcSEcCtD
Amisulpride—Dizziness—Goserelin—prostate cancer	0.000479	0.000644	CcSEcCtD
Amisulpride—Somnolence—Mitoxantrone—prostate cancer	0.000476	0.00064	CcSEcCtD
Amisulpride—Dizziness—Conjugated Estrogens—prostate cancer	0.000474	0.000638	CcSEcCtD
Amisulpride—Convulsion—Etoposide—prostate cancer	0.000472	0.000635	CcSEcCtD
Amisulpride—Angiopathy—Docetaxel—prostate cancer	0.000472	0.000635	CcSEcCtD
Amisulpride—Dyspepsia—Mitoxantrone—prostate cancer	0.000471	0.000633	CcSEcCtD
Amisulpride—Hypertension—Etoposide—prostate cancer	0.000471	0.000633	CcSEcCtD
Amisulpride—Immune system disorder—Docetaxel—prostate cancer	0.00047	0.000632	CcSEcCtD
Amisulpride—Gastrointestinal pain—Estradiol—prostate cancer	0.00047	0.000631	CcSEcCtD
Amisulpride—Cardiac disorder—Capecitabine—prostate cancer	0.000468	0.000629	CcSEcCtD
Amisulpride—Orthostatic hypotension—Epirubicin—prostate cancer	0.000464	0.000623	CcSEcCtD
Amisulpride—Fatigue—Mitoxantrone—prostate cancer	0.000461	0.00062	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000461	0.00062	CcSEcCtD
Amisulpride—Vomiting—Goserelin—prostate cancer	0.000461	0.000619	CcSEcCtD
Amisulpride—Constipation—Mitoxantrone—prostate cancer	0.000458	0.000615	CcSEcCtD
Amisulpride—Angiopathy—Capecitabine—prostate cancer	0.000457	0.000615	CcSEcCtD
Amisulpride—Bradycardia—Prednisone—prostate cancer	0.000457	0.000615	CcSEcCtD
Amisulpride—Vomiting—Conjugated Estrogens—prostate cancer	0.000456	0.000613	CcSEcCtD
Amisulpride—Urticaria—Estradiol—prostate cancer	0.000456	0.000613	CcSEcCtD
Amisulpride—Mental disorder—Docetaxel—prostate cancer	0.000456	0.000613	CcSEcCtD
Amisulpride—Immune system disorder—Capecitabine—prostate cancer	0.000455	0.000612	CcSEcCtD
Amisulpride—Abdominal pain—Estradiol—prostate cancer	0.000454	0.00061	CcSEcCtD
Amisulpride—Headache—Goserelin—prostate cancer	0.000454	0.00061	CcSEcCtD
Amisulpride—Malnutrition—Docetaxel—prostate cancer	0.000453	0.000609	CcSEcCtD
Amisulpride—Headache—Conjugated Estrogens—prostate cancer	0.000449	0.000604	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—prostate cancer	0.000447	0.000601	CcSEcCtD
Amisulpride—Mental disorder—Capecitabine—prostate cancer	0.000442	0.000594	CcSEcCtD
Amisulpride—Malnutrition—Capecitabine—prostate cancer	0.000439	0.00059	CcSEcCtD
Amisulpride—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000437	0.000588	CcSEcCtD
Amisulpride—Muscle spasms—Docetaxel—prostate cancer	0.000436	0.000586	CcSEcCtD
Amisulpride—Skin disorder—Etoposide—prostate cancer	0.000432	0.000581	CcSEcCtD
Amisulpride—Nausea—Goserelin—prostate cancer	0.00043	0.000579	CcSEcCtD
Amisulpride—Hyperhidrosis—Etoposide—prostate cancer	0.00043	0.000579	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—prostate cancer	0.000429	0.000577	CcSEcCtD
Amisulpride—Nausea—Conjugated Estrogens—prostate cancer	0.000426	0.000573	CcSEcCtD
Amisulpride—Urticaria—Mitoxantrone—prostate cancer	0.000425	0.000572	CcSEcCtD
Amisulpride—Hypersensitivity—Estradiol—prostate cancer	0.000423	0.000569	CcSEcCtD
Amisulpride—Abdominal pain—Mitoxantrone—prostate cancer	0.000423	0.000569	CcSEcCtD
Amisulpride—Muscle spasms—Capecitabine—prostate cancer	0.000422	0.000567	CcSEcCtD
Amisulpride—Hypotension—Etoposide—prostate cancer	0.000416	0.000559	CcSEcCtD
Amisulpride—Asthenia—Estradiol—prostate cancer	0.000412	0.000554	CcSEcCtD
Amisulpride—Tremor—Capecitabine—prostate cancer	0.000411	0.000553	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—prostate cancer	0.00041	0.000552	CcSEcCtD
Amisulpride—Angiopathy—Prednisone—prostate cancer	0.000407	0.000548	CcSEcCtD
Amisulpride—Pruritus—Estradiol—prostate cancer	0.000406	0.000546	CcSEcCtD
Amisulpride—Leukopenia—Docetaxel—prostate cancer	0.000406	0.000545	CcSEcCtD
Amisulpride—Immune system disorder—Prednisone—prostate cancer	0.000406	0.000545	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—prostate cancer	0.000399	0.000537	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—prostate cancer	0.000397	0.000534	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—prostate cancer	0.000396	0.000532	CcSEcCtD
Amisulpride—Somnolence—Etoposide—prostate cancer	0.000396	0.000532	CcSEcCtD
Amisulpride—Hypersensitivity—Mitoxantrone—prostate cancer	0.000394	0.00053	CcSEcCtD
Amisulpride—Mental disorder—Prednisone—prostate cancer	0.000393	0.000529	CcSEcCtD
Amisulpride—Diarrhoea—Estradiol—prostate cancer	0.000393	0.000528	CcSEcCtD
Amisulpride—Leukopenia—Capecitabine—prostate cancer	0.000393	0.000528	CcSEcCtD
Amisulpride—Convulsion—Docetaxel—prostate cancer	0.000393	0.000528	CcSEcCtD
Amisulpride—Hypertension—Docetaxel—prostate cancer	0.000391	0.000526	CcSEcCtD
Amisulpride—Malnutrition—Prednisone—prostate cancer	0.000391	0.000526	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Etoposide—prostate cancer	0.000384	0.000517	CcSEcCtD
Amisulpride—Asthenia—Mitoxantrone—prostate cancer	0.000384	0.000516	CcSEcCtD
Amisulpride—Fatigue—Etoposide—prostate cancer	0.000384	0.000516	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—prostate cancer	0.000383	0.000516	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000383	0.000515	CcSEcCtD
Amisulpride—Constipation—Etoposide—prostate cancer	0.000381	0.000512	CcSEcCtD
Amisulpride—Dizziness—Estradiol—prostate cancer	0.00038	0.000511	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—prostate cancer	0.00038	0.00051	CcSEcCtD
Amisulpride—Hypertension—Capecitabine—prostate cancer	0.000379	0.000509	CcSEcCtD
Amisulpride—Dry mouth—Docetaxel—prostate cancer	0.000377	0.000507	CcSEcCtD
Amisulpride—Anxiety—Capecitabine—prostate cancer	0.000372	0.000501	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000371	0.000499	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—prostate cancer	0.000369	0.000497	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—prostate cancer	0.000367	0.000494	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—prostate cancer	0.000366	0.000492	CcSEcCtD
Amisulpride—Diarrhoea—Mitoxantrone—prostate cancer	0.000366	0.000492	CcSEcCtD
Amisulpride—Dry mouth—Capecitabine—prostate cancer	0.000365	0.000491	CcSEcCtD
Amisulpride—Vomiting—Estradiol—prostate cancer	0.000365	0.000491	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—prostate cancer	0.000365	0.000491	CcSEcCtD
Amisulpride—Gastrointestinal pain—Etoposide—prostate cancer	0.000364	0.000489	CcSEcCtD
Amisulpride—Nervous system disorder—Docetaxel—prostate cancer	0.000363	0.000488	CcSEcCtD
Amisulpride—Headache—Estradiol—prostate cancer	0.00036	0.000484	CcSEcCtD
Amisulpride—Skin disorder—Docetaxel—prostate cancer	0.000359	0.000483	CcSEcCtD
Amisulpride—Agitation—Prednisone—prostate cancer	0.000359	0.000483	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—prostate cancer	0.000357	0.000481	CcSEcCtD
Amisulpride—Angioedema—Prednisone—prostate cancer	0.000357	0.00048	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000355	0.000477	CcSEcCtD
Amisulpride—Urticaria—Etoposide—prostate cancer	0.000354	0.000475	CcSEcCtD
Amisulpride—Abdominal pain—Etoposide—prostate cancer	0.000352	0.000473	CcSEcCtD
Amisulpride—Nervous system disorder—Capecitabine—prostate cancer	0.000351	0.000472	CcSEcCtD
Amisulpride—Skin disorder—Capecitabine—prostate cancer	0.000348	0.000468	CcSEcCtD
Amisulpride—Hyperhidrosis—Capecitabine—prostate cancer	0.000346	0.000466	CcSEcCtD
Amisulpride—Hypotension—Docetaxel—prostate cancer	0.000346	0.000465	CcSEcCtD
Amisulpride—Nausea—Estradiol—prostate cancer	0.000341	0.000459	CcSEcCtD
Amisulpride—Vomiting—Mitoxantrone—prostate cancer	0.00034	0.000457	CcSEcCtD
Amisulpride—Convulsion—Prednisone—prostate cancer	0.000339	0.000455	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—prostate cancer	0.000338	0.000454	CcSEcCtD
Amisulpride—Hypertension—Prednisone—prostate cancer	0.000337	0.000454	CcSEcCtD
Amisulpride—Headache—Mitoxantrone—prostate cancer	0.000335	0.000451	CcSEcCtD
Amisulpride—Hypotension—Capecitabine—prostate cancer	0.000335	0.00045	CcSEcCtD
Amisulpride—Insomnia—Docetaxel—prostate cancer	0.000335	0.00045	CcSEcCtD
Amisulpride—Anxiety—Prednisone—prostate cancer	0.000332	0.000446	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—prostate cancer	0.000331	0.000445	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00033	0.000444	CcSEcCtD
Amisulpride—Somnolence—Docetaxel—prostate cancer	0.000329	0.000442	CcSEcCtD
Amisulpride—Hypersensitivity—Etoposide—prostate cancer	0.000328	0.000441	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—prostate cancer	0.000326	0.000438	CcSEcCtD
Amisulpride—Dyspepsia—Docetaxel—prostate cancer	0.000326	0.000438	CcSEcCtD
Amisulpride—Insomnia—Capecitabine—prostate cancer	0.000324	0.000436	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000319	0.000429	CcSEcCtD
Amisulpride—Asthenia—Etoposide—prostate cancer	0.000319	0.000429	CcSEcCtD
Amisulpride—Fatigue—Docetaxel—prostate cancer	0.000319	0.000429	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—prostate cancer	0.000319	0.000428	CcSEcCtD
Amisulpride—Nausea—Mitoxantrone—prostate cancer	0.000318	0.000427	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—prostate cancer	0.000317	0.000426	CcSEcCtD
Amisulpride—Constipation—Docetaxel—prostate cancer	0.000316	0.000425	CcSEcCtD
Amisulpride—Dyspepsia—Capecitabine—prostate cancer	0.000315	0.000424	CcSEcCtD
Amisulpride—Pruritus—Etoposide—prostate cancer	0.000315	0.000423	CcSEcCtD
Amisulpride—Nervous system disorder—Prednisone—prostate cancer	0.000313	0.000421	CcSEcCtD
Amisulpride—Skin disorder—Prednisone—prostate cancer	0.00031	0.000417	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000309	0.000416	CcSEcCtD
Amisulpride—Fatigue—Capecitabine—prostate cancer	0.000309	0.000415	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisone—prostate cancer	0.000308	0.000415	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—prostate cancer	0.000308	0.000414	CcSEcCtD
Amisulpride—Constipation—Capecitabine—prostate cancer	0.000306	0.000412	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—prostate cancer	0.000306	0.000411	CcSEcCtD
Amisulpride—Diarrhoea—Etoposide—prostate cancer	0.000304	0.000409	CcSEcCtD
Amisulpride—Gastrointestinal pain—Docetaxel—prostate cancer	0.000302	0.000407	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—prostate cancer	0.000302	0.000405	CcSEcCtD
Amisulpride—Tension—Epirubicin—prostate cancer	0.0003	0.000403	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—prostate cancer	0.000297	0.000399	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—prostate cancer	0.000295	0.000396	CcSEcCtD
Amisulpride—Dizziness—Etoposide—prostate cancer	0.000294	0.000396	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—prostate cancer	0.000294	0.000395	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—prostate cancer	0.000293	0.000395	CcSEcCtD
Amisulpride—Gastrointestinal pain—Capecitabine—prostate cancer	0.000293	0.000394	CcSEcCtD
Amisulpride—Abdominal pain—Docetaxel—prostate cancer	0.000292	0.000393	CcSEcCtD
Amisulpride—Insomnia—Prednisone—prostate cancer	0.000288	0.000388	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—prostate cancer	0.000285	0.000383	CcSEcCtD
Amisulpride—Urticaria—Capecitabine—prostate cancer	0.000284	0.000383	CcSEcCtD
Amisulpride—Abdominal pain—Capecitabine—prostate cancer	0.000283	0.000381	CcSEcCtD
Amisulpride—Vomiting—Etoposide—prostate cancer	0.000283	0.000381	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—prostate cancer	0.000283	0.00038	CcSEcCtD
Amisulpride—Agitation—Epirubicin—prostate cancer	0.000281	0.000378	CcSEcCtD
Amisulpride—Dyspepsia—Prednisone—prostate cancer	0.000281	0.000378	CcSEcCtD
Amisulpride—Headache—Etoposide—prostate cancer	0.000279	0.000375	CcSEcCtD
Amisulpride—Tension—Doxorubicin—prostate cancer	0.000278	0.000373	CcSEcCtD
Amisulpride—Fatigue—Prednisone—prostate cancer	0.000275	0.00037	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—prostate cancer	0.000275	0.000369	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—prostate cancer	0.000274	0.000368	CcSEcCtD
Amisulpride—Constipation—Prednisone—prostate cancer	0.000273	0.000367	CcSEcCtD
Amisulpride—Hypersensitivity—Docetaxel—prostate cancer	0.000272	0.000366	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—prostate cancer	0.000272	0.000366	CcSEcCtD
Amisulpride—Asthenia—Docetaxel—prostate cancer	0.000265	0.000357	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—prostate cancer	0.000265	0.000356	CcSEcCtD
Amisulpride—Nausea—Etoposide—prostate cancer	0.000264	0.000355	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—prostate cancer	0.000264	0.000355	CcSEcCtD
Amisulpride—Hypersensitivity—Capecitabine—prostate cancer	0.000264	0.000355	CcSEcCtD
Amisulpride—Pruritus—Docetaxel—prostate cancer	0.000262	0.000352	CcSEcCtD
Amisulpride—Gastrointestinal pain—Prednisone—prostate cancer	0.000261	0.000351	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—prostate cancer	0.00026	0.00035	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—prostate cancer	0.000259	0.000349	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000258	0.000348	CcSEcCtD
Amisulpride—Asthenia—Capecitabine—prostate cancer	0.000257	0.000345	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—prostate cancer	0.000254	0.000342	CcSEcCtD
Amisulpride—Urticaria—Prednisone—prostate cancer	0.000253	0.000341	CcSEcCtD
Amisulpride—Pruritus—Capecitabine—prostate cancer	0.000253	0.000341	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—prostate cancer	0.000253	0.00034	CcSEcCtD
Amisulpride—Diarrhoea—Docetaxel—prostate cancer	0.000253	0.00034	CcSEcCtD
Amisulpride—Abdominal pain—Prednisone—prostate cancer	0.000252	0.000339	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—prostate cancer	0.000245	0.00033	CcSEcCtD
Amisulpride—Diarrhoea—Capecitabine—prostate cancer	0.000245	0.000329	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—prostate cancer	0.000245	0.000329	CcSEcCtD
Amisulpride—Dizziness—Docetaxel—prostate cancer	0.000245	0.000329	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—prostate cancer	0.000244	0.000328	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—prostate cancer	0.000242	0.000326	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—prostate cancer	0.000241	0.000324	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—prostate cancer	0.00024	0.000323	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000239	0.000322	CcSEcCtD
Amisulpride—Dizziness—Capecitabine—prostate cancer	0.000237	0.000318	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—prostate cancer	0.000235	0.000317	CcSEcCtD
Amisulpride—Vomiting—Docetaxel—prostate cancer	0.000235	0.000316	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisone—prostate cancer	0.000235	0.000316	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—prostate cancer	0.000233	0.000313	CcSEcCtD
Amisulpride—Headache—Docetaxel—prostate cancer	0.000232	0.000312	CcSEcCtD
Amisulpride—Asthenia—Prednisone—prostate cancer	0.000229	0.000308	CcSEcCtD
Amisulpride—Vomiting—Capecitabine—prostate cancer	0.000228	0.000306	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—prostate cancer	0.000226	0.000304	CcSEcCtD
Amisulpride—Pruritus—Prednisone—prostate cancer	0.000226	0.000303	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—prostate cancer	0.000226	0.000303	CcSEcCtD
Amisulpride—Headache—Capecitabine—prostate cancer	0.000224	0.000302	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—prostate cancer	0.000224	0.000301	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—prostate cancer	0.000223	0.0003	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—prostate cancer	0.000222	0.000298	CcSEcCtD
Amisulpride—Nausea—Docetaxel—prostate cancer	0.00022	0.000295	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—prostate cancer	0.00022	0.000295	CcSEcCtD
Amisulpride—Diarrhoea—Prednisone—prostate cancer	0.000218	0.000293	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—prostate cancer	0.000216	0.00029	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000215	0.00029	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—prostate cancer	0.000215	0.000289	CcSEcCtD
Amisulpride—Constipation—Epirubicin—prostate cancer	0.000213	0.000287	CcSEcCtD
Amisulpride—Nausea—Capecitabine—prostate cancer	0.000213	0.000286	CcSEcCtD
Amisulpride—Dizziness—Prednisone—prostate cancer	0.000211	0.000284	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—prostate cancer	0.000209	0.000281	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—prostate cancer	0.000205	0.000276	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—prostate cancer	0.000204	0.000274	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—prostate cancer	0.000203	0.000273	CcSEcCtD
Amisulpride—Vomiting—Prednisone—prostate cancer	0.000203	0.000273	CcSEcCtD
Amisulpride—Headache—Prednisone—prostate cancer	0.0002	0.000269	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000199	0.000268	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—prostate cancer	0.000199	0.000268	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—prostate cancer	0.000198	0.000267	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—prostate cancer	0.000197	0.000265	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—prostate cancer	0.000197	0.000265	CcSEcCtD
Amisulpride—Nausea—Prednisone—prostate cancer	0.000189	0.000255	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000189	0.000254	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—prostate cancer	0.000184	0.000247	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—prostate cancer	0.000183	0.000247	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—prostate cancer	0.000182	0.000245	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—prostate cancer	0.000179	0.000241	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—prostate cancer	0.000176	0.000237	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—prostate cancer	0.000171	0.00023	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—prostate cancer	0.00017	0.000229	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—prostate cancer	0.000166	0.000223	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—prostate cancer	0.000165	0.000222	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—prostate cancer	0.000163	0.00022	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—prostate cancer	0.000159	0.000213	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—prostate cancer	0.000158	0.000212	CcSEcCtD
Amisulpride—Headache—Epirubicin—prostate cancer	0.000156	0.00021	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—prostate cancer	0.000153	0.000205	CcSEcCtD
Amisulpride—Nausea—Epirubicin—prostate cancer	0.000148	0.000199	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—prostate cancer	0.000147	0.000197	CcSEcCtD
Amisulpride—Headache—Doxorubicin—prostate cancer	0.000145	0.000194	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—prostate cancer	0.000137	0.000184	CcSEcCtD
Amisulpride—DRD2—GPCR downstream signaling—CXCL8—prostate cancer	2.52e-05	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—JAK2—prostate cancer	2.51e-05	0.000151	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAP2K1—prostate cancer	2.5e-05	0.00015	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1R—prostate cancer	2.49e-05	0.00015	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CD—prostate cancer	2.48e-05	0.000149	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL8—prostate cancer	2.48e-05	0.000149	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BAD—prostate cancer	2.48e-05	0.000149	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GSK3B—prostate cancer	2.48e-05	0.000149	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—JAK2—prostate cancer	2.47e-05	0.000149	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—PIK3CA—prostate cancer	2.46e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SERPINE1—prostate cancer	2.45e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—INS—prostate cancer	2.44e-05	0.000147	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—KRAS—prostate cancer	2.43e-05	0.000146	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LPL—prostate cancer	2.43e-05	0.000146	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2—prostate cancer	2.41e-05	0.000145	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFRB—prostate cancer	2.41e-05	0.000145	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—prostate cancer	2.4e-05	0.000144	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APC—prostate cancer	2.4e-05	0.000144	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CREBBP—prostate cancer	2.39e-05	0.000144	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LPL—prostate cancer	2.39e-05	0.000144	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—prostate cancer	2.38e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGF2—prostate cancer	2.38e-05	0.000143	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGF—prostate cancer	2.37e-05	0.000143	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IRS1—prostate cancer	2.37e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—prostate cancer	2.37e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFRB—prostate cancer	2.37e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IGF1—prostate cancer	2.36e-05	0.000142	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—EGFR—prostate cancer	2.35e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ITGB3—prostate cancer	2.35e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—prostate cancer	2.34e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—prostate cancer	2.34e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ITGB3—prostate cancer	2.31e-05	0.000139	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GSK3B—prostate cancer	2.3e-05	0.000139	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—prostate cancer	2.29e-05	0.000138	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAP2K1—prostate cancer	2.28e-05	0.000137	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JAK2—prostate cancer	2.28e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB3—prostate cancer	2.27e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—INS—prostate cancer	2.27e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR2—prostate cancer	2.27e-05	0.000137	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—prostate cancer	2.27e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—prostate cancer	2.25e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—prostate cancer	2.25e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—prostate cancer	2.24e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB3—prostate cancer	2.24e-05	0.000135	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR2—prostate cancer	2.23e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—prostate cancer	2.23e-05	0.000134	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CREBBP—prostate cancer	2.23e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MDM2—prostate cancer	2.22e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—prostate cancer	2.22e-05	0.000134	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—prostate cancer	2.2e-05	0.000132	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ERBB2—prostate cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—prostate cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—prostate cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—prostate cancer	2.18e-05	0.000131	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGF2—prostate cancer	2.17e-05	0.000131	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—prostate cancer	2.16e-05	0.00013	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—prostate cancer	2.15e-05	0.00013	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—prostate cancer	2.15e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—prostate cancer	2.14e-05	0.000129	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAP2K1—prostate cancer	2.12e-05	0.000128	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—prostate cancer	2.11e-05	0.000127	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—prostate cancer	2.09e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—prostate cancer	2.09e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—prostate cancer	2.09e-05	0.000125	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JAK2—prostate cancer	2.08e-05	0.000125	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—prostate cancer	2.08e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—prostate cancer	2.07e-05	0.000124	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—prostate cancer	2.05e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—prostate cancer	2.04e-05	0.000123	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—prostate cancer	2.04e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MDM2—prostate cancer	2.03e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1B—prostate cancer	2.03e-05	0.000122	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGF2—prostate cancer	2.02e-05	0.000122	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CAV1—prostate cancer	2.02e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—prostate cancer	2.01e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ERBB2—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—prostate cancer	2e-05	0.000121	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—prostate cancer	1.99e-05	0.00012	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—prostate cancer	1.99e-05	0.00012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—prostate cancer	1.99e-05	0.00012	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—prostate cancer	1.99e-05	0.00012	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CAV1—prostate cancer	1.98e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—prostate cancer	1.98e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—prostate cancer	1.98e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—prostate cancer	1.96e-05	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—prostate cancer	1.94e-05	0.000117	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—prostate cancer	1.94e-05	0.000117	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JAK2—prostate cancer	1.94e-05	0.000117	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CTNNB1—prostate cancer	1.92e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—prostate cancer	1.91e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—prostate cancer	1.9e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—prostate cancer	1.9e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BAD—prostate cancer	1.9e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MDM2—prostate cancer	1.89e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—prostate cancer	1.88e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1A—prostate cancer	1.87e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—prostate cancer	1.87e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BAD—prostate cancer	1.87e-05	0.000112	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ERBB2—prostate cancer	1.86e-05	0.000112	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1B—prostate cancer	1.86e-05	0.000112	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—prostate cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—prostate cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APC—prostate cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—prostate cancer	1.84e-05	0.00011	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—prostate cancer	1.82e-05	0.00011	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—prostate cancer	1.82e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGF—prostate cancer	1.82e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IRS1—prostate cancer	1.82e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—prostate cancer	1.82e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—prostate cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APC—prostate cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—prostate cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGF—prostate cancer	1.79e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IRS1—prostate cancer	1.79e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EP300—prostate cancer	1.78e-05	0.000107	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—prostate cancer	1.77e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—prostate cancer	1.77e-05	0.000106	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GSK3B—prostate cancer	1.76e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CTNNB1—prostate cancer	1.75e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—INS—prostate cancer	1.74e-05	0.000105	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GSK3B—prostate cancer	1.73e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—prostate cancer	1.73e-05	0.000104	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1B—prostate cancer	1.73e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—prostate cancer	1.72e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1A—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—INS—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—prostate cancer	1.71e-05	0.000103	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CREBBP—prostate cancer	1.7e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—prostate cancer	1.69e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—prostate cancer	1.69e-05	0.000102	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—prostate cancer	1.69e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CREBBP—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—prostate cancer	1.67e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—prostate cancer	1.67e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—prostate cancer	1.67e-05	0.0001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—prostate cancer	1.65e-05	9.96e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—prostate cancer	1.65e-05	9.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—prostate cancer	1.65e-05	9.91e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CTNNB1—prostate cancer	1.63e-05	9.81e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EP300—prostate cancer	1.63e-05	9.8e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAP2K1—prostate cancer	1.63e-05	9.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—prostate cancer	1.61e-05	9.72e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	1.6e-05	9.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAP2K1—prostate cancer	1.6e-05	9.63e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—prostate cancer	1.6e-05	9.62e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—prostate cancer	1.6e-05	9.61e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1A—prostate cancer	1.59e-05	9.59e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—prostate cancer	1.59e-05	9.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—prostate cancer	1.59e-05	9.56e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—prostate cancer	1.58e-05	9.53e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—prostate cancer	1.58e-05	9.51e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—prostate cancer	1.57e-05	9.47e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—prostate cancer	1.57e-05	9.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—prostate cancer	1.56e-05	9.36e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—prostate cancer	1.55e-05	9.35e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—prostate cancer	1.55e-05	9.33e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—prostate cancer	1.55e-05	9.33e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF2—prostate cancer	1.55e-05	9.31e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—prostate cancer	1.54e-05	9.29e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—prostate cancer	1.53e-05	9.19e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—prostate cancer	1.52e-05	9.18e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF2—prostate cancer	1.52e-05	9.16e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—prostate cancer	1.52e-05	9.14e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EP300—prostate cancer	1.52e-05	9.12e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—prostate cancer	1.5e-05	9.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JAK2—prostate cancer	1.48e-05	8.92e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—prostate cancer	1.47e-05	8.87e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JAK2—prostate cancer	1.46e-05	8.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	1.45e-05	8.74e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MDM2—prostate cancer	1.45e-05	8.71e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—prostate cancer	1.44e-05	8.64e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—prostate cancer	1.44e-05	8.64e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—prostate cancer	1.43e-05	8.6e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB2—prostate cancer	1.43e-05	8.58e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MDM2—prostate cancer	1.42e-05	8.57e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—prostate cancer	1.42e-05	8.56e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—prostate cancer	1.42e-05	8.54e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—prostate cancer	1.42e-05	8.52e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—prostate cancer	1.41e-05	8.47e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB2—prostate cancer	1.4e-05	8.45e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—prostate cancer	1.39e-05	8.36e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—prostate cancer	1.38e-05	8.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—prostate cancer	1.35e-05	8.14e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—prostate cancer	1.33e-05	8.01e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1B—prostate cancer	1.32e-05	7.95e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—prostate cancer	1.32e-05	7.95e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—prostate cancer	1.32e-05	7.94e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—prostate cancer	1.32e-05	7.93e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—prostate cancer	1.31e-05	7.89e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—prostate cancer	1.31e-05	7.86e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	1.3e-05	7.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—prostate cancer	1.29e-05	7.79e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—prostate cancer	1.29e-05	7.78e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—prostate cancer	1.29e-05	7.78e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—prostate cancer	1.29e-05	7.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	1.29e-05	7.74e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—prostate cancer	1.28e-05	7.68e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—prostate cancer	1.27e-05	7.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—prostate cancer	1.27e-05	7.65e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—prostate cancer	1.27e-05	7.62e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—prostate cancer	1.26e-05	7.58e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CTNNB1—prostate cancer	1.25e-05	7.51e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—prostate cancer	1.24e-05	7.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	1.23e-05	7.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—prostate cancer	1.22e-05	7.36e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—prostate cancer	1.22e-05	7.35e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1A—prostate cancer	1.22e-05	7.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—prostate cancer	1.22e-05	7.32e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.21e-05	7.25e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.2e-05	7.24e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.2e-05	7.22e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.2e-05	7.2e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.19e-05	7.14e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—prostate cancer	1.17e-05	7.03e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.17e-05	7.03e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—prostate cancer	1.17e-05	7.02e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EP300—prostate cancer	1.16e-05	6.98e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EP300—prostate cancer	1.14e-05	6.87e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—prostate cancer	1.13e-05	6.79e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.12e-05	6.75e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—prostate cancer	1.11e-05	6.68e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.1e-05	6.61e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—prostate cancer	1.09e-05	6.55e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—prostate cancer	1.08e-05	6.53e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.08e-05	6.51e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—prostate cancer	1.08e-05	6.48e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.07e-05	6.44e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—prostate cancer	1.07e-05	6.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—prostate cancer	1.01e-05	6.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.01e-05	6.07e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—prostate cancer	9.95e-06	5.99e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—prostate cancer	9.93e-06	5.98e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—prostate cancer	9.92e-06	5.97e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—prostate cancer	9.89e-06	5.95e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—prostate cancer	9.84e-06	5.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—prostate cancer	9.73e-06	5.85e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—prostate cancer	9.34e-06	5.62e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—prostate cancer	9.19e-06	5.53e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—prostate cancer	9.16e-06	5.51e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—prostate cancer	8.58e-06	5.16e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	8.44e-06	5.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—prostate cancer	8.3e-06	5e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—prostate cancer	8.17e-06	4.92e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—prostate cancer	7.6e-06	4.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—prostate cancer	7.48e-06	4.5e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—prostate cancer	7.01e-06	4.22e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—prostate cancer	6.9e-06	4.15e-05	CbGpPWpGaD
